Calosyn Pharma, Inc. — Form C (Regulation Crowdfunding)
Calosyn Pharma, Inc. of Shreveport, LA filed a Form C (Regulation Crowdfunding) with the SEC on 2025-09-30. Target raise $20K, up to $1.2M. Offered through StartEngine Primary, LLC.
Offering
- Filed: 2025-09-30
- Form: C
- Accession: 0001429819-25-000003
- Target amount: $20K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 20,000
- Deadline: 2025-12-29
- Funding portal / intermediary: StartEngine Primary, LLC
- Intermediary file number: 008-70060
Issuer
- CIK: 0001429819
- Website: https://www.calosyn.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2007-09-21
- Address: 2031 Kings Highway, Shreveport, LA, 71103
- Employees: 3
Financials (as filed)
- Total assets (most recent): $164K
- Cash (most recent): $147K
- Net income (most recent): $-638K
- Net income (prior): $-768K
- Short-term debt: $436K
- Long-term debt: $2.4M
People (5)
| Name | Role | Location |
|---|
| Richard Babb | Chief Financial Officer, Board Observer and Treasurer | Hammond, LA |
| Ross Pryor Barrett | Board Member | Shreveport, LA |
| Joe Lovett | Board Member | Shreveport, LA |
| Reid Grimes | CEO, Board Member | Shreveport, LA |
| David D. Waddell | Board Member, Founder, and Chief Medical Officer | Shreveport, LA |
Reg CF filing history (3)
More